Cardiology (all articles)
Reviews | Antiarrhythmic drugs and anesthesia
11 Jan, 2023 | 14:06h | UTCAntiarrhythmic drugs and anaesthesia: part 1. mechanisms of cardiac arrhythmias – BJA Education
Antiarrhythmic drugs and anaesthesia. Part 2: pharmacotherapy – BJA Education
Review | Predictors of early heart failure rehospitalization among older adults with preserved and reduced ejection fraction
11 Jan, 2023 | 13:58h | UTC
Restoring mortality data in the FOURIER trial of evolocumab in patients with CVD: a reanalysis based on regulatory data
10 Jan, 2023 | 14:49h | UTCCommentaries:
Yet Another Story on Re-Analyzing a Major Trial – Sensible Medicine
Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees – TCTMD
M-A | Prospective association of daily steps with cardiovascular disease
10 Jan, 2023 | 14:29h | UTCProspective Association of Daily Steps With Cardiovascular Disease: A Harmonized Meta-Analysis – Circulation (link to abstract – $ for full-text)
Commentaries:
CVD Benefits of Activity Seen Below Widely Quoted Step Goal in Older Adults – TCTMD
Heart health tip for older adults in 2023: Step it up a bit – University of Massachusetts Amherst
Commentary on Twitter
#OriginalResearch: In a meta-analysis of 8 studies, 6,000 to 9,000 steps/day was associated with 40% to 50% lower risk of CVD among older adults #AHAJournals https://t.co/fEA1EFyhTI pic.twitter.com/T6LXFGZoVb
— Circulation (@CircAHA) December 21, 2022
Cohort Study | Risk of heart failure in congenital heart disease
10 Jan, 2023 | 14:14h | UTCNews Release: Heart failure more common in heart defect survivors starting at young age – American Heart Association
M-A | Techniques improving electrical cardioversion success for patients with atrial fibrillation
10 Jan, 2023 | 14:12h | UTC
ESC/AHA/ACC/WHF Joint Opinion | Randomized trials fit for the 21st century
9 Jan, 2023 | 14:44h | UTCCommentaries:
It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies – TCTMD
Commentary on Twitter
Together with @ACCinTouch @escardio & @worldheartfed, we are positioned to push, guide and support the remodeling of #RCTs for the 21st century. #RedesignRCTs
Read the joint statement in @circaha: https://t.co/hoypaSp10m pic.twitter.com/vwMGx0tksz
— AHA Science (@AHAScience) December 16, 2022
The year in cardiovascular medicine 2022: the top 10 papers in acute cardiac care and ischemic heart disease
9 Jan, 2023 | 14:28h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardiovascular Imaging https://t.co/OVJxxYu71p@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #cvimaging @chiarabd @NAjmoneMarsan pic.twitter.com/sooF0bz3LN
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in dyslipidemias
9 Jan, 2023 | 14:26h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Dyslipidaemia https://t.co/jpkqgt4Hf1 @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #dyslipidemia pic.twitter.com/UBfKy45mAu
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
9 Jan, 2023 | 14:10h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Heart Failure and Cardiomyopathies https://t.co/w6opcMPcBa@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #HeartFailure #Cardiomyopathies pic.twitter.com/UrrX2LUQdI
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardiovascular imaging
9 Jan, 2023 | 14:21h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Acute Cardiac Care and Ischaemic Heart Disease https://t.co/nRNjEyAeDR@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #cvacute #ischaemic #heartdisease pic.twitter.com/qCoug19mNJ
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in arrhythmias
9 Jan, 2023 | 14:19h | UTCThe year in cardiovascular medicine 2022: the top 10 papers in arrhythmias – European Heart Journal
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Arrhythmias https://t.co/D3GM1l8TgW@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #CVD #arrhythmias pic.twitter.com/kxXqyEx8KM
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
The year in cardiovascular medicine 2022: the top 10 papers in cardio-oncology
9 Jan, 2023 | 14:08h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Cardio-oncology https://t.co/hfWJ94MmxK@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes @mayocvonc #cardioonco #CVD @TeresaLpezFdez1 pic.twitter.com/30SNvdvkEV
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
Left heart catheterization complications | ED presentations, evaluation, and management
9 Jan, 2023 | 14:07h | UTCLeft Heart Catheterization Complications: ED Presentations, Evaluation, and Management – emDocs
RCT | Chlorthalidone (12.5-25 mg) and Hydrochlorothiazide (25-50 mg) are similarly effective for the prevention of CVD in hypertensive patients.
16 Dec, 2022 | 13:49h | UTCChlorthalidone vs. Hydrochlorothiazide for Hypertension–Cardiovascular Events – New England Journal of Medicine (link to abstract – $ for full-text)
Related (news release and commentaries before publication): RCT | Chlortalidone and Hydrochlorothiazide resulted in similar reductions of CVD in older patients with hypertension.
Commentary on Twitter
Patients 65 years or older with hypertension who switched from chlorthalidone to hydrochlorothiazide did not have fewer major cardiovascular events or non–cancer-related deaths than those who continued receiving hydrochlorothiazide. https://t.co/9xAiSZzxio pic.twitter.com/bIVOOiVDve
— NEJM (@NEJM) December 14, 2022
Cohort Study | Association of the triglyceride glucose index as a measure of insulin resistance with mortality and CVD
9 Jan, 2023 | 13:42h | UTCInvited Commentary: The triglyceride glucose index and cardiovascular disease outcomes – The Lancet Health Longevity
Updated Guidance | Acute, periprocedural and long-term antithrombotic therapy in older adults.
16 Dec, 2022 | 13:51h | UTCCommentary: Antithrombotic Therapy in Older Adults: Key Points – American College of Cardiology
Associations between extreme temperatures and cardiovascular cause-specific mortality: results from 27 countries.
15 Dec, 2022 | 13:44h | UTCNews Release: About 1 in 100 heart disease deaths linked to extreme hot and cold weather days – University of Maryland School of Medicine
Special Report | Global burden of cardiovascular diseases and risks collaboration.
14 Dec, 2022 | 15:57h | UTCHomepage and Infographic: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology
News Release: New report tracks latest trends in global cardiovascular health – Institute for Health Metrics and Evaluation
Full Report: Global Burden of Cardiovascular Diseases and Risks Collaboration – Journal of the American College of Cardiology
Commentary on Twitter
🆕 Special @JACCJournals Issue Tracks Latest Trends in Global Burden of CVD
The issue looks at data addressing 18 specific CV conditions and 15 risk factors from 21 regions & 204 countries & territories. Learn more: https://t.co/w1PmJ98KrW #CardioTwitter pic.twitter.com/JCTQsr4dLK
— American College of Cardiology (@ACCinTouch) December 12, 2022
Research Opportunities in the treatment of mitral valve prolapse: JACC Expert Panel.
14 Dec, 2022 | 15:10h | UTC
M-A | Predicting neurological outcome in adult patients with cardiac arrest.
14 Dec, 2022 | 15:02h | UTC
Cohort Study | Assessment of depression and adherence to guideline-directed medical therapies following PCI.
14 Dec, 2022 | 14:59h | UTCCommentaries:
SR | BNP and NT-proBNP for the diagnosis of hemodynamically significant patent ductus arteriosus in preterm neonates.
14 Dec, 2022 | 14:49h | UTC
AHA Scientific Statement | Management of acute coronary syndrome in the older adult population.
13 Dec, 2022 | 14:35h | UTCNews Release: Hearts and bodies change with age, heart disease treatments may need to change, too – American Heart Association
Top Things to Know: Management of ACS in the Older Adult Population – American Heart Association
Commentaries:
The Management of ACS in Older Patients: Is Age Just a Number? – American Heart Association
Review | GLP-1 receptor agonists for the reduction of atherosclerotic cardiovascular risk in patients with Type 2 Diabetes.
13 Dec, 2022 | 14:29h | UTCGLP-1 Receptor Agonists for the Reduction of Atherosclerotic Cardiovascular Risk in Patients With Type 2 Diabetes – Circulation (free for a limited period)